Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiolitis. Origins and optimal management

M L Everard1

  • 1Sheffield Children's Hospital, England.

Drugs
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Acute bronchiolitis, primarily caused by respiratory syncytial virus, continues to challenge infant health. Improved supportive care has reduced mortality, but effective vaccines and treatments remain elusive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current options in aerosolised drug therapy for children receiving respiratory support.

Anaesthesia·2017
Same author

International consensus on (ICON) pediatric asthma.

Allergy·2012
Same author

Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis.

Paediatric respiratory reviews·2011
Same author

What the pulmonary specialist should know about the new inhalation therapies.

The European respiratory journal·2011
Same author

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach.

The European respiratory journal·2008
Same author

Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis.

Pediatric pulmonology·2008
Same journal

Ecnoglutide: First Approvals.

Drugs·2026
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
See all related articles

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Acute bronchiolitis causes significant infant morbidity, posing a threat to infants with underlying health conditions.
  • Respiratory syncytial virus (RSV) is the primary cause, with incomplete understanding of viral-host interactions hindering vaccine development.
  • Current treatments for acute bronchiolitis have seen little change in over 30 years.

Purpose of the Study:

  • To review the current state of acute bronchiolitis management and prevention.
  • To highlight challenges in vaccine development and novel therapy efficacy.
  • To emphasize the importance of supportive care and infection control.

Main Methods:

  • Literature review of acute bronchiolitis epidemiology, treatment, and prevention.

Related Experiment Videos

  • Analysis of current management strategies including supportive care and monitoring.
  • Assessment of the role of antiviral agents and novel therapies.

    • Main Results:

    • Mortality in at-risk infants has decreased due to improved intensive and supportive care.
    • The efficacy of antiviral ribavirin is unclear, and other novel therapies have not altered the disease's natural course.
    • Strict adherence to infection control measures is the only current effective preventive intervention.

    Conclusions:

    • Acute bronchiolitis remains a significant pediatric challenge with no immediate vaccine prospects.
    • Supportive care and intensive management have improved outcomes, but effective treatments are lacking.
    • Preventing nosocomial infections is crucial for managing this widespread infant illness.